ADIM
ADNT icon

Alpha DNA Investment Management’s Adient ADNT Stock Holding History

Alpha DNA Investment Management’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36
Closed -$1K – 110
2021
Q1 		$1K Buy
+36
New +$1.36K ﹤0.01% 602

Other funds holding ADNT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LAM
Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Alpha DNA Investment Management's ADNT Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Adient (ADNT) in Q2 2021, closing a stake of 36 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in ADNT in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 290 funds tracked by Wall St. Rank hold ADNT as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Adient position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 36 Adient shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Adient in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Adient position peaked at $1K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Adient as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.